LAPOINTE ANTHONY GREGG
SEC insider (Form 3/4/5 filer). CIK 0001331860. Director at SOLIGENIX, INC. (SNGX) and 2 other issuers. 17 reported Form 4/5 transactions since Sep 2024; latest on Oct 12, 2026. Located in PRINCETON, NJ.
Companies LAPOINTE ANTHONY GREGG has filed insider reports for
- SOLIGENIX, INC. (SNGX): Director
- RIGEL PHARMACEUTICALS INC (RIGL): Director
- Astria Therapeutics, Inc. (ATXS): Director
LAPOINTE ANTHONY GREGG
CIK: 0001331860
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Oct 12, 2026SNGX
SOLIGENIX, INC.
DispositionDirectStock Option (Right to Buy)
63 shares- - Oct 12, 2026SNGX
SOLIGENIX, INC.
DispositionDirectStock Option (Right to Buy)
192 shares- - Oct 12, 2026SNGX
SOLIGENIX, INC.
DispositionDirectStock Option (Right to Buy)
121 shares- - Oct 12, 2026SNGX
SOLIGENIX, INC.
DispositionDirectStock Option (Right to Buy)
128 shares- - Oct 12, 2026SNGX
SOLIGENIX, INC.
DispositionDirectStock Option (Right to Buy)
74 shares- - Oct 12, 2026SNGX
SOLIGENIX, INC.
DispositionDirectStock Option (Right to Buy)
54 shares- - Sep 17, 2026SNGX
SOLIGENIX, INC.
AwardDirectStock Option (Right to Buy)
78.9K shares- - May 15, 2026RIGL
RIGEL PHARMACEUTICALS INC
AwardDirect5.8K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
26.6K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
16.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 12, 2026 |  SNGX SOLIGENIX, INC. | Disposition Stock Option (Right to Buy) | 63 | - | - | Direct |
| Oct 12, 2026 | SNGX SOLIGENIX, INC. | Disposition Stock Option (Right to Buy) | 192 | - | - | Direct |
| Oct 12, 2026 | SNGX SOLIGENIX, INC. | Disposition Stock Option (Right to Buy) | 121 | - | - | Direct |
| Oct 12, 2026 | SNGX SOLIGENIX, INC. | Disposition Stock Option (Right to Buy) | 128 | - | - | Direct |
| Oct 12, 2026 | SNGX SOLIGENIX, INC. | Disposition Stock Option (Right to Buy) | 74 | - | - | Direct |
| Oct 12, 2026 | SNGX SOLIGENIX, INC. | Disposition Stock Option (Right to Buy) | 54 | - | - | Direct |
| Sep 17, 2026 | SNGX SOLIGENIX, INC. | Award Stock Option (Right to Buy) | 78,947 | - | - | Direct |
| May 15, 2026 |  RIGL RIGEL PHARMACEUTICALS INC | Award | 5,750 | - | $0 | Direct |
| Jan 23, 2026 |  ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 26,550 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 16,666 | - | - | Direct |
1-10 of 17 transactions